These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 28539163)
1. A quantitative comparison of anti-Müllerian hormone measurement and its shifting boundaries between two assays. de Kat AC; Broekmans FJM; van Westing AC; Lentjes E; Verschuren WMM; van der Schouw YT Maturitas; 2017 Jul; 101():12-16. PubMed ID: 28539163 [TBL] [Abstract][Full Text] [Related]
2. A single-centre evaluation of two new anti-Mullerian hormone assays and comparison with the current clinical standard assay. Welsh P; Smith K; Nelson SM Hum Reprod; 2014 May; 29(5):1035-41. PubMed ID: 24578473 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of the Ultrasensitive Anti-Müllerian Hormone Assay for Predicting True Ovarian Reserve. Iwase A; Osuka S; Nakamura T; Kato N; Takikawa S; Goto M; Kikkawa F Reprod Sci; 2016 Jun; 23(6):756-60. PubMed ID: 26614267 [TBL] [Abstract][Full Text] [Related]
4. Comparability of antimüllerian hormone levels among commercially available immunoassays. Su HI; Sammel MD; Homer MV; Bui K; Haunschild C; Stanczyk FZ Fertil Steril; 2014 Jun; 101(6):1766-72.e1. PubMed ID: 24726216 [TBL] [Abstract][Full Text] [Related]
5. Differing performance of two assays for the measurement of anti-Mullerian hormone in premenopausal women: A cross-sectional study. Bell RJ; Skiba MA; Sikaris K; Liu A; Islam RM; Davis SR Clin Endocrinol (Oxf); 2021 Jul; 95(1):169-175. PubMed ID: 33705583 [TBL] [Abstract][Full Text] [Related]
6. Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Rustamov O; Smith A; Roberts SA; Yates AP; Fitzgerald C; Krishnan M; Nardo LG; Pemberton PW Hum Reprod; 2012 Oct; 27(10):3085-91. PubMed ID: 22777530 [TBL] [Abstract][Full Text] [Related]
7. Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay. Han X; McShane M; Sahertian R; White C; Ledger W Hum Reprod; 2014 May; 29(5):1042-8. PubMed ID: 24626805 [TBL] [Abstract][Full Text] [Related]
8. Age-related Curves of AMH Using the Gen II, the picoAMH, and the Elecsys Assays in Women With Polycystic Ovary Syndrome. Barbagallo F; van der Ham K; Willemsen SP; Louwers YV; Laven JS J Clin Endocrinol Metab; 2024 Sep; 109(10):2561-2570. PubMed ID: 38486510 [TBL] [Abstract][Full Text] [Related]
9. Performance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assay. van Helden J; Weiskirchen R Hum Reprod; 2015 Aug; 30(8):1918-26. PubMed ID: 26093541 [TBL] [Abstract][Full Text] [Related]
10. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline. de Kat AC; van der Schouw YT; Eijkemans MJ; Herber-Gast GC; Visser JA; Verschuren WM; Broekmans FJ BMC Med; 2016 Oct; 14(1):151. PubMed ID: 27716302 [TBL] [Abstract][Full Text] [Related]
11. Non-equivalence of anti-Müllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing. Iliodromiti S; Salje B; Dewailly D; Fairburn C; Fanchin R; Fleming R; Li HWR; Lukaszuk K; Ng EHY; Pigny P; Tadros T; van Helden J; Weiskirchen R; Nelson SM Hum Reprod; 2017 Aug; 32(8):1710-1715. PubMed ID: 28854583 [TBL] [Abstract][Full Text] [Related]
12. The association of low ovarian reserve with cardiovascular disease risk: a cross-sectional population-based study. de Kat AC; Verschuren WM; Eijkemans MJ; van der Schouw YT; Broekmans FJ Hum Reprod; 2016 Aug; 31(8):1866-74. PubMed ID: 27496945 [TBL] [Abstract][Full Text] [Related]
13. Relationship between anti-Müllerian hormone and antral follicle count across the menstrual cycle using the Beckman Coulter Access assay in comparison with Gen II manual assay. Schiffner J; Roos J; Broomhead D; Helden JV; Godehardt E; Fehr D; Freundl G; Johnson S; Gnoth C Clin Chem Lab Med; 2017 Jun; 55(7):1025-1033. PubMed ID: 27987358 [TBL] [Abstract][Full Text] [Related]
14. Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay. Köninger A; Schmidt B; Mach P; Damaske D; Nießen S; Kimmig R; Strowitzki T; Gellhaus A Reprod Biol Endocrinol; 2015 Aug; 13():86. PubMed ID: 26250904 [TBL] [Abstract][Full Text] [Related]
15. A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II). Wallace AM; Faye SA; Fleming R; Nelson SM Ann Clin Biochem; 2011 Jul; 48(Pt 4):370-3. PubMed ID: 21628625 [TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of three new commercial immunoassays for anti-Müllerian hormone measurement. Li HW; Wong BP; Ip WK; Yeung WS; Ho PC; Ng EH Hum Reprod; 2016 Dec; 31(12):2796-2802. PubMed ID: 27702835 [TBL] [Abstract][Full Text] [Related]
17. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation? Burks HR; Ross L; Opper N; Paulson E; Stanczyk FZ; Chung K Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904 [TBL] [Abstract][Full Text] [Related]
18. The original Beckman Coulter Generation II assay significantly underestimates AMH levels compared with the revised protocol. Bonifacio M; Bradley CK; Karia S; Livingstone M; Bowman MC; McArthur SJ J Assist Reprod Genet; 2015 Nov; 32(11):1691-6. PubMed ID: 26466940 [TBL] [Abstract][Full Text] [Related]